American Society of Hematology

SHERPA: Blue

People

  1. O'Reilly
    O'Reilly
  2. Zelenetz
    Zelenetz
  3. Kernan
    Kernan
  4. Moore
    Moore
  5. Papadopoulos
    Papadopoulos
  6. Young
    Young
  7. Castro-Malaspina
    Castro-Malaspina
  8. Jakubowski
    Jakubowski
  9. Perales
    Perales
  10. Scheinberg
    Scheinberg

Groups

  1. Department of Medicine (64)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (42)
  4. Sloan Kettering Institute Faculty (42)
  5. GSK Faculty (32)
  6. Tow Center for Developmental Oncology (TCDO) (24)
  7. Center for Molecular Imaging and Biotechnology (22)
  8. Immunology Program Faculty (22)
  9. Pediatrics, Department of (21)
  10. Stem Cell Transplantation and Cellular Therapy Service (19)
Search Within
  1. "2002"
Formats
  1. Meeting Abstract (78)
  2. Journal Article (22)
Groups
  1. Department of Medicine (64)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (42)
  4. Sloan Kettering Institute Faculty (42)
  5. GSK Faculty (32)
  6. Tow Center for Developmental Oncology (TCDO) (24)

More Groups

People
  1. Richard O'Reilly (16)
  2. Stephen Nimer (15)
  3. Andrew Zelenetz (13)
  4. Pier Pandolfi Derinaldis (13)
  5. Nancy Kernan (12)
  6. Malcolm Moore (10)

More People

Years
  1. 2002 (100)
Publications
  1. Blood (100)

Results (100)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytoreduction with HFTBI, thiotepa and fludarabine without antithymocyte globulin (ATG) permits consistent and sustained engraftment of HLA-matched related, T-cell depleted peripheral blood stem cell (PBSC)/bone marrow (BM) transplants in adults with hematologic malignancies
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Young, J.; Perales, M. A.; Castro-Malaspina, H.; Van Den Brink, M.; Thomas, A. E.; Kernan, N. A.; O'Reilly, R. J.
    Blood (2002)

    Fulltext@MSK | Save
  • Long term remission with T-cell depleted marrow transplants from related or unrelated donors for advanced non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Perales, M. A.; Lee, S. S. E.; Childs, B. H.; Castro-Malaspina, H.; Jakubowski, A.; Papadopoulos, E. B.; Boulad, F.; Small, T. N.; Wolden, S.; Collins, N. H.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Comparative quantification of umbilical-cord blood CD34+cells using the ProCOUNT-BD and ISHAGE Protocols with evaluation of CD34+bright cells
    Meeting Abstract

    Pranke, P.; Hendrikx, J.; Alespeite, G.; Nardi, N.; Rubinstein, P.; Visser, J.
    Blood (2002)

    Fulltext@MSK | Save
  • A novel intracellular cytokine flow cytometry assay to analyze alloreactive T cells following allogeneic bone marrow transplantation (BMT)
    Meeting Abstract

    Alpdogan, O.; Perales, M. A.; van den Brink, M. R. M.
    Blood (2002)

    Fulltext@MSK | Save
  • Sex steroid ablation enhances immune reconstitution following allogeneic bone marrow transplantation
    Meeting Abstract

    Goldberg, G. L.; Alpdogan, O.; Muriglan, S. J.; Willis, L. M.; Greenberg, A. S.; Boyd, R. L.; van den Brink, M. R. M.
    Blood (2002)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Gencarelli, A.; Scheinberg, D. A.; Maslak, P. G.; Horgan, D.
    Blood (2002)

    Fulltext@MSK | Save
  • Patients with transformed low grade lymphoma attain durable responses following outpatient radioimmunotherapy with tositumomab and iodine I 131 tositumomab [Bexxar (R)]
    Meeting Abstract

    Zelenetz, A. D.; Saleh, M.; Vose, J.; Younes, A.; Kaminski, M. S.
    Blood (2002)

    Fulltext@MSK | Save
  • Bexxar (R) radioimmunotherapy produces a substantial number of durable complete responses in patents with multiply relapsed or refractory low grade or transformed love grade non-Hodgkin's lymphoma
    Meeting Abstract

    Kaminski, M. S.; Zelenetz, A.; Leonard, J.; Saleh, M.; Jain, V.
    Blood (2002)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with Bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in acute myeloid leukemia (AML)
    Meeting Abstract

    Burke, J. M.; Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • A "first in man" study of the safety and PK/PD of an oral FLT3 inhibitor (MLN518) in patients with AML or high risk myelodysplasia
    Meeting Abstract

    Heinrich, M. C.; Druker, B. J.; Curtin, P. T.; Paquette, R.; Sawyers, C. L.; De Angelo, D. J.; Gilliland, G. D.; Stone, R. M.; Caliguiri, M. A.; Byrd, J. C.; more...
    Blood (2002)

    Fulltext@MSK | Save